Health Care Corporate Governance: Guidelines for Board Decision-Making Regarding Major Transactions
- June 07, 2024
Rob Gerberry, Senior Vice President and Chief Legal Officer, Summa Health, speaks with Michael Peregrine, Partner, McDermott Will & Emery, about the role of health care corporate boards in reviewing major transactions. They discuss key elements of corporate policies related to transactions, the board’s standard of conduct when reviewing transactions, how to handle transactions that are not consummated, common fiduciary “landmines,” and management’s role in navigating transaction activity.
You must be logged in to access this content.